Drug Database
Back to search

Poland· PL-100138327

99mTc - Tektrotyd

A 99mtc-technetium hynic-octreotid product containing technetium 99mtc-hynic-tyr^3-octeotide, registered in Poland by Narodowe Centrum Badań Jądrowych. The same ATC class is registered in 7 of our 19 countries.

ATC V09IA07

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalised99mTc - TektrotydATCV09IA07REGISTER NO.PL-100138327PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about technetium 99mtc-hynic-tyr^3-octeotideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

99mtc-technetium hynic-octreotid is registered in 7 of 19 countries.

Countries holding a registration under ATC V09IA07 (99mtc-technetium hynic-octreotid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose
Search 99mtc-technetium hynic-octreotid products by name

99mtc-technetium hynic-octreotid · ATC V09IA07

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Technetium 99mTc-HYNIC-Tyr^3-Octeotide
Manufacturer
Narodowe Centrum Badań Jądrowych
Country
Poland (PL)
ATC code
V09IA07
ATC class
99mTc-Technetium hynic-octreotid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991166410

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under V09IA07

99mtc-technetium hynic-octreotid, as other registers publish it.

All 99mtc-technetium hynic-octreotid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9c54bcb8-5c3a-47de-a9e8-24d0b1b20423
GET /v1/drugs/9c54bcb8-5c3a-47de-a9e8-24d0b1b20423?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Liofilizat do sporządzania roztworu do wstrzykiwań",
  "source": "urpl",
  "strength": "16 mcg HYNIC-[De-Phe^1, Tyr^3-Oktreotyd] TFA",
  "packaging": "05909991166410 ¦ Lz ¦ 54629\n1 zestaw  dwufiolkowy",
  "substance": "HYNIC-[D-Phe1, Tyr3-Octreotidum] *TFA 20 mcg (fiolka I)",
  "common_name": "Technetium 99mTc-HYNIC-Tyr^3-Octeotide",
  "pl_product_id": "100138327",
  "pozwolenie_nr": "11664",
  "auth_procedure": "NAR",
  "authorisation_validity": "2024-04-02"
}
API referenceMCP serverPlans

See everything about 99mtc-technetium hynic-octreotid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console